findmyKOL
Clinical trialNCT04146571AvailableExpanded Access

Expanded Access to Ensartinib for Participants With ALK+ NSCLC

SponsorXcovery Holdings, Inc.ALK Gene Rearrangement PositiveNon-Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an open-label, multicenter, intermediate-sized expanded access treatment protocol to the existing IND 111,695 for ensartinib (X-396). The treatment plan is designed to provide ensartinib to participants with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC).
clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Stanford, California, United States

    Heather Wakelee, M.D.
    Available
  • Walter Reed National Military Medical Center

    Bethesda, Maryland, United States

    Alden Chiu, M.D.
    Available
  • Vanderbilt University

    Nashville, Tennessee, United States

    Sally York, MD
    Available
  • University of Wisconsin Carbone Cancer Ctr

    Madison, Wisconsin, United States

    Anne Traynor, M.D.
    Available

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ensartinib
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
—
Last update posted
20 Oct 2022
Registered enrollment
—
Registry id
NCT04146571
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.